About Us

AJK Biopharmaceutical was founded in 2018 with a mission to combat life–threatening infectious diseases. We are focused on the clinical development of novel anti-infective drugs with emphasis on developing broad-spectrum antimicrobial cyclic peptides with activity against multi-drug resistant bacteria, anti-fungal and antiviral peptides.



Our Mission

AJK Biopharmaceutical is committed to discovering and developing antimicrobial agents that are effective against several drug-resistant bacterial pathogens, thus providing health care practitioners with critical new approaches to infections disease therapy.

AJK Biopharmaceutical

Org chart

Teams

Similar companies